It is a business services public limited company based in Delhi, Delhi, India, established in 2016.
2016 | Delhi, Delhi, India | Struck OffBioarise Pharmaceuticals Limited, a struck off public limited company, was established on 18 November 2016 in Delhi, Delhi, India. Engaging in other services within the business services sector, it holds CIN: U74999DL2016PLC308340. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Formerly known as Arise Pharmaceuticals Limited. It upholds a compliant status. Its leadership includes Sunil Malhotra (Additional Director), Abhishek Jain (Additional Director), Prithvi Raj Saigal (Director). Past directors included Sunil Malhotra, Abhishek Jain, Ishani Saigal. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at 105, First Floor, H - 10, Express Arcade Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
U74999DL2016PLC308340
308340
18 November 2016
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Bioarise Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Malhotra | Additional Director | 22 Feb 2017 | Current |
| Abhishek Jain | Additional Director | 06 Apr 2017 | Current |
| Prithvi Raj Saigal | Director | 18 Nov 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 17 Feb 2018 | Past |
| Pramod Abcsdd | Director | 22 Feb 2017 | Past |
| Pramod Abcsdd | Director | 06 Apr 2017 | Past |
| Pramod Abcsdd | Director | 15 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bioarise Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Bioarise Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bioarise Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bioarise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioarise Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bioarise Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.
Progress on Abhishek Jain was appointed as a Additional Director was appointed as a Additional Director on 06 Apr 2017 & has been associated with this company since 8 years 7 months . was documented.
Bioarise Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Delhi. was recorded as a recent event.
Sunil Malhotra was appointed as a Additional Director was appointed as a Additional Director on 22 Feb 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.
The activity Prithvi Raj Saigal was appointed as a Director was appointed as a Director on 18 Nov 2016 & has been associated with this company since 9 years 11 days . was completed.
The activity Bioarise Pharmaceuticals Limited was registered on 18 Nov 2016 with Roc Delhi & aged 9 years 11 days as per MCA records. was completed.
The CIN of Bioarise Pharmaceuticals Limited is U74999DL2016PLC308340.
Bioarise Pharmaceuticals Limited is headquartered at 105, First Floor, H - 10, Express Arcade Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
Bioarise Pharmaceuticals Limited was incorporated on 18 November 2016.
The current directors of Bioarise Pharmaceuticals Limited are
The primary industry of Bioarise Pharmaceuticals Limited is Business Services.
Bioarise Pharmaceuticals Limited is unlisted.
The authorized capital of Bioarise Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Bioarise Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX